Ultragenyx Pharmaceutical Inc. buy Truist Financial Co.
Start price
05.11.25
/
50%
€27.80
Target price
05.11.26
€78.31
Performance (%)
-28.53%
Price
10.04.26
€19.70
Summary
This prediction is currently active. The price of Ultragenyx Pharmaceutical Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -28.53%. This prediction currently runs until 05.11.26. The prediction end date can be changed by Truist_Financial_Co_ at any time. Truist_Financial_Co_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Ultragenyx Pharmaceutical Inc. | 2.073% | 2.073% |
| iShares Core DAX® | 2,55 % | 0,56 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % |
| iShares S&P 500 | 1,93 % | -0,51 % |
Comments by Truist_Financial_Co_ for this prediction
In the thread Ultragenyx Pharmaceutical Inc. diskutieren
Ultragenyx Pharmaceutical (NASDAQ:RARE) had its price target lowered by analysts at Truist Financial Corporation from $100.00 to $90.00. They now have a "buy" rating on the stock.
Ratings data for RARE provided by MarketBeat